Evidence map›Paper›PMID 35630773›Full record

ArticleMolecules (Basel, Switzerland)2022

Visible Light-Driven Alkyne-Grafted Ethylene-Bridged Azobenzene Chromophores for Photothermal Utilization.

Wenyu Fang, Yiyu Feng, Jian Gao, Hui Wang, Jing Ge, Qingbin Yang, Wei Feng

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenyu FangSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.
Yiyu FengSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.
Jian GaoSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.
Hui WangSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.
Jing GeSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.
Qingbin YangSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.
Wei FengSchool of Materials Science and Engineering, Tianjin University, Tianjin 300350, China.

Funding

the National Natural Science Foundation of China No. 51973152the Science Foundation for Distinguished Young Scholars in Tianjin No. 19JCJQJC61700the State Key Program of National Natural Science Foundation of China No. 52130303
6 · The paper itself

Abstract

Molecular photoswitches are considered to be important candidates in the field of solar energy storage due to their sensitive and reversible bidirectional optical response. Nevertheless, it is still a daunting challenge to design a molecular photoswitch to improve the low solar spectrum utilization and quantum yields while achieving charging and discharging of heat without solvent assistance. Herein, a series of visible-light-driven ethylene-bridged azobenzene (b-Azo) chromophores with different alkyne substituents which can undergo isomerization reactions promoted in both directions by visible light are reported. Their visible light responsiveness improves their solar spectrum utilization while also having high quantum yields. In addition, as the compounds are liquids, there is no need to dissolve the compounds in order to exploit this switching. The photoisomerization of b-Azo can be adjusted by alkyne-related substituents, and hexyne-substituted b-Azo is able to store and release photothermal energy with a high density of 106.1 J·g

Indexed as

azobenzenephotoresponsephotothermal utilizationsolar energy storagevisible-light driven

Identifiers

PMID35630773
PMCPMC9145641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.